Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2002
11/21/2002WO2002092076A1 Substituted coumarins and quinolines as caspases activators
11/21/2002WO2002070507A3 Glycorticoid receptor antagonists for treatment of diabetes
11/21/2002WO2002057246A3 Inhibitors of cruzipain and other cysteine proteases
11/21/2002WO2002055514A3 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
11/21/2002WO2002022598A8 Quinolinone derivatives as tyrosine kinase inhibitors
11/21/2002US20020173667 Use in photochromic articles such as lenses; 2H-naphtho(1,2-b)pyran structure characterized by having an aromatic substituent in the 5 position
11/21/2002US20020173645 Acylating a 2-aryl-6-alkoxy-benzo(b)thiophene with a p-(tertiaryaminoethoxy)benzoic acid hydrohalide salt or the corresponding benzoyl halide in presence of a boron trihalide
11/21/2002US20020173631 4-((5,5-dimethyl-5,6,7,8-tetrahydro-8-hydroxynaphthalen-2 -yl)carbonyloxy)benzoic acid, benzyl ester for example; receptor subtype selectivity for side effect reduction
11/21/2002US20020173536 Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
11/21/2002US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002US20020173518 Anticoagulant in mammls
11/21/2002US20020173515 Antiproliferative agents
11/21/2002US20020170125 Bridged diaminopyrazole compounds and dye compositions containing same
11/21/2002DE10125294A1 New heterocyclylmethyl-substituted anthranilamide derivatives and analogs as KDR/FLT tyrosine kinase inhibitors, used for treating e.g. psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/21/2002CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002CA2446797A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/20/2002EP1258252A1 Integrin expression inhibitors
11/20/2002EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/20/2002EP1257550A1 Platelet adp receptor inhibitors
11/20/2002EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002EP1257543A1 Pyridinylimidazoles
11/20/2002EP1150969B1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence
11/20/2002CN1380882A C10 ester substituted taxanes as antitumor agents
11/20/2002CN1380289A Amide capable of inhibiting ApoB-secretion/MTP
11/19/2002US6482963 C9 hydrido, hydroxy and acyloxy taxane derivatives and pharmaceutical compositions containing them
11/19/2002US6482956 Endothelin receptor antagonists
11/19/2002US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/18/2002WO2001087878A1 Novel benzothiophene derivatives
11/18/2002WO2001087855A1 Triazole derivatives
11/18/2002CA2409821A1 Novel benzothiophene derivatives
11/15/2002WO2001087875A1 Novel benzofuran derivatives
11/15/2002CA2409096A1 Novel benzofuran derivatives
11/14/2002WO2002090355A1 N-aroyl cyclic amines
11/14/2002WO2002090353A1 Sulfonamides
11/14/2002WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002WO2002090348A1 Sulfonamides
11/14/2002WO2002090347A1 Amide compounds
11/14/2002WO2002090346A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002WO2002090342A1 Chromene compound
11/14/2002WO2002090336A1 Substituted arylketones
11/14/2002WO2002090334A1 Isoquinolinone derivatives as parp inhibitors
11/14/2002WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002WO2002089793A1 Sulfonamides
11/14/2002WO2002089792A1 Sulfonamides
11/14/2002WO2002089785A1 Sulfonamides
11/14/2002WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002WO2002081453A8 Thiohydantoins and use thereof for treating diabetes
11/14/2002WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002US20020169322 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
11/14/2002US20020169313 Of carbonyl compounds with secondary amines in the presence of a water scavenger, preferably trifluoroacetic acid; preparation of imidazole-containing benzodiazepines, which are inhibitors of farnesyl protein transferase
11/14/2002US20020169203 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
11/14/2002US20020169198 Agonists of the progesterone receptor; contraceptives, hormone replacement therapy and treating menopause symptoms
11/14/2002US20020169188 Modulating neurotransmission in the central nervous system
11/14/2002US20020169161 Bicyclic sulfanimde compounds useful for the treatment of cardiac arrhythmias
11/14/2002US20020169155 A nitrogen-ring containing triheterocyclic compound is useful for treating a disease associated with aberrant leukocyte recruitment and/or activation
11/14/2002DE10136449A1 Substituierte Arylketone Substituted aryl ketones
11/14/2002CA2453223A1 Selective anthranilamide pyridinamides as vegfr-2 and vegfr-3 inhibitors
11/14/2002CA2449187A1 Substituted arylketones
11/14/2002CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002CA2446396A1 N-aroyl cyclic amines
11/14/2002CA2446365A1 Sulfonamides
11/14/2002CA2446120A1 Novel arylheteroalkylamine derivatives
11/14/2002CA2446051A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002CA2444531A1 Isoquinolinone derivatives as parp inhibitors
11/13/2002EP1255740A2 Substituted arylpyrazines
11/13/2002EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002EP1255735A2 Pyridine derivatives as potentiators of glutamate receptors
11/13/2002EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002EP1255536A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
11/13/2002EP1140916B1 Heteroaryl-cyclic acetals
11/13/2002EP1012139B1 Azetidinone derivatives as beta-lactamase inhibitors
11/13/2002EP0912515B1 1,4-di-substituted piperidines as muscarinic antagonists
11/13/2002CN1379777A Amino-triazolopyridine derivatives
11/13/2002CN1379774A Compounds
11/13/2002CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002CN1379764A Benzodiazepine derivatives
11/13/2002CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/13/2002CN1379666A Non-peptide GnRH agents, methods and intermediates for their preparation
11/12/2002US6479678 Metal alkoxide taxane and β-lactam compounds
11/12/2002US6479554 Immunotherapeutic agents
11/12/2002US6479536 Benzofuran derivatives, process for the preparation of the same and uses thereof
11/12/2002US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002US6479517 Treatment of post-menopausal syndrome: osteoporosis, cardiovascular effects such as hyperlipidemia, and estrogen-dependent cancer, particularly breast and uterine cancer
11/12/2002US6479514 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
11/12/2002US6479508 Viral polymerase inhibitors
11/12/2002US6479505 6-arylphenanthridines with PDE-IV inhibiting activity
11/12/2002US6479504 Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
11/12/2002US6479495 Simultaneously treating depression and memory dysfunction in mammals suffering from memory dysfunction and depression
1 ... 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 ... 523